Crescent Biopharma, Inc. (CBIO) — Financial Flexibility Index
Crescent Biopharma, Inc. (CBIO) has a Financial Flexibility Index of -1.00x as of June 2026. Free cash flow of $-19.45 Million (operating CF $-19.46 Million minus capex $13.00K) represents -1% of total liabilities ($19.50 Million). Check Crescent Biopharma, Inc. (CBIO) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Crescent Biopharma, Inc. Financial Flexibility Index (2011–2025)
Historical Financial Flexibility Index trend for Crescent Biopharma, Inc. across 15 annual periods. For the full cash flow conversion analysis, see CBIO operating cash flow.
Annual Financial Flexibility Index for Crescent Biopharma, Inc. (2011–2025)
Year-by-year free cash flow to debt coverage for Crescent Biopharma, Inc.. Explore debt repayment capacity of Crescent Biopharma, Inc. to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.04x | $1.39 Million | $-71.53 Million | $37.28 Million | ▲ +106.1% |
| 2024 | -0.61x | $-31.09 Million | $-31.10 Million | $51.10 Million | ▲ +88.0% |
| 2023 | -5.05x | $-34.86 Million | $-34.88 Million | $6.90 Million | ▲ +3.3% |
| 2022 | -5.22x | $-46.37 Million | $-46.46 Million | $8.88 Million | ▼ -15.8% |
| 2021 | -4.51x | $-57.47 Million | $-57.49 Million | $12.74 Million | ▼ -68.2% |
| 2020 | -2.68x | $-39.17 Million | $-39.24 Million | $14.61 Million | ▲ +28.8% |
| 2019 | -3.76x | $-51.84 Million | $-51.98 Million | $13.77 Million | ▲ +18.3% |
| 2018 | -4.61x | $-43.21 Million | $-43.33 Million | $9.38 Million | ▼ -38.9% |
| 2017 | -3.32x | $-29.47 Million | $-29.77 Million | $8.88 Million | ▲ +19.0% |
| 2016 | -4.10x | $-29.03 Million | $-29.73 Million | $7.09 Million | ▼ -310.4% |
| 2015 | -1.00x | $-7.97 Million | $-8.24 Million | $7.99 Million | ▼ -58.4% |
| 2014 | -0.63x | $-4.07 Million | $-4.28 Million | $6.46 Million | ▲ +90.3% |
| 2013 | -6.51x | $-15.46 Million | $-15.54 Million | $2.38 Million | ▼ -277.3% |
| 2012 | -1.72x | $-10.16 Million | $-10.47 Million | $5.89 Million | ▼ -351.2% |
| 2011 | 0.69x | $14.04 Million | $13.85 Million | $20.45 Million | — |